San Francisco, California 94107


The investigators are studying the ability of F18 labeled fluorocholine PET to localize parathyroid adenomas in patients with hyperparathyroidism prior to surgery.


Inclusion Criteria: - Biochemically proven hyperparathyroidism and an indication for surgery - Age ≥ 13 years - Karnofsky performance status of > 50 (or ECOG/WHO equivalent). - Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: - Patients exceeding the weight limitations of the scanner or are not able to enter the bore of the PET scanner due to BMI. - Inability to lie still for the entire imaging time (e.g. cough, severe arthritis, etc.). - Inability to complete the needed investigational due to other reasons (severe claustrophobia, radiation phobia, etc.). - Pregnancy.



Primary Contact:

Principal Investigator
Insoo Soo, MD
University of California, San Francisco

Maya Aslam

Backup Contact:


Location Contact:

San Francisco, California 94107
United States

Thomas Hope, MD

Site Status: Recruiting

Data Source:

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.